K.S. Anthony

Subscribe

K.S. Anthony

I am a New York City-based writer and marketing strategist with a proven track record of successful growth and optimization strategies in today's volatile environment.

As a writer, I have earned hundreds of millions of page views and over a billion Facebook impressions. In addition, I have written branded content, feature-length screenplays, Billboard-charting song lyrics, and edited thousands of news articles, graduate and undergraduate research papers, college application essays, and more. 

In marketing, I differentiate myself through unconventional thinking, flexibility and excellence in tactics and strategy, the performance of those I recruit, and the speed and efficacy with which my teams and I deliver results. 
 
I graduated cum laude from Columbia University with a B.A. in English and am proud to be an honorary G-Chief (civilian advisor) in the NYC Chapter of the Special Forces Association. 

SumZero •

SubPrime Bull: Fund Manager Judd Arnold Says KPLT's "land grab" in BNPL is a BUY NOW

8/16/21 Update: LCRM's Judd Arnold reports that he has closed his position on KPLT: details are here https://sumzero.com/pro/research/ideas/19975. Lake Cornelia Research Management CIO discusses his bullish thesis on Katapult Holdings Ltd. (US: KPLT) with SumZero CEO Divya Narendra. Read Judd's 60 page memo for free with a SumZero login here: https://sumzero.com/pro/research/ideas/19975 Presentation slides available here: https://www.icloud.com/iclouddrive/09I_mT6N3SVvX2XSbdQcRSZ3A#LCRM_KPLT_CALL_8-2-21 For more fundamentally-driven investment research on stocks as well as crypto, please join https://www.SumZero.com. 00:00 Start 00:10 Divya Narendra intro 00:40 Buy Now, Pay Later (BNPL) trend in consumer spending 00:50 Square (US: SQ) acquisition of AfterPay 01:05 Jargon 01:24 Judd Arnold intro and discussion of BNPL and subprime financing space 01:45 BNPL segmented across verticals 02:13 "Pay 4", Average Order Value, (AOV) and BNPL (Slide 7) 03:15 Advantages of financing over credit cards 03:33 Volume of receivables 03:55 Square and the AfterPay deal 04:12 AfterPay's penetration in the Australian market 04:26 KPLT's higher AOV 04:37 Competition from Acima and Progressive (US:PRG) 05:02 Market demographics, subprime credit customers 05:11 Wayfair (US: W), furniture, and auto parts 05:29 7-month average on KPLT leases 07:18 Savings relative to compounded credit card interest 07:43 How defaults are handled 09:10 How payments are handled 09:44 The two things American consumers can't live without 10:44 BNPL and bad debt expense 11:01 Direct lender OPFI's 35 - 40% credit losses 11:20 KPLT's 3% credit losses 11:40 Is KPLT pure fintech? (Slide 11) 12:06 PRG has over 2000 employees 12:18 KPLT has 80-90 employees 12:43 KPLT partnership with Affirm (US: AFRM) 14:11 KPLT's free cash flow (Slide 20) 15:30 How KPLT manages client credit risk 16:00 Credit data granularity "beyond FICO scores" 16:57 Algorithms bidding on extending credit to Wayfair customers 17:10 "KPLT winning on two fronts" 17:30 KPLT bidding aggressively on existing customers 18:10 KPLT holds data for 1.5M subprime credit customers 18:20 KPLT algos faster to respond than competition 19:05 Integration, diversification, partnerships 19:25 Quarterly revenue determinants 21:35 Addressing concern's about Wayfair's '21 Q2 (Slide 17) 22:18 "Wayfair risk isn't about the quarter" (Slide 16) 22:45 KPLT's partnership with Wayfair is an advantage 23:25 Total addressable market 23:54 Customer acquisition potential (Slide 15) 24:48 Most small merchants only have one subprime solution 25:40 "This is all a land grab right now" 27:15 PRG's 3 biggest customers 27:43 BNPL market is growing 29:20 KPLT history, founders, and early investors 31:58 KPLT's relationship with CURO Group (US:CURO) 32:16 KPLT 30-40% of CURO's market cap 32:26 How KPLT went public: SPAC, PIPE investors, etc 36:16 Recent dip and free cash flow 39:50 KPLT's investments in growth 41:00 Understanding KPLT's business (Slide 20) 41:41 Biggest threats to KPLT 42:31 Waterfall partnership with AFRM (Slide 9) 43:53 Barriers to entry in subprime 45:54 Macro-risks to BNPL in COVID-19 era 48:20 Square/AfterPay and KPLT's recent performance 49:35 PIPE unlock likely a non-event 50:45 Q2 earnings expectations (Slide 14) 52:03 Possible catalysts 55:15 Target price by end of 2022 56:45 Kafene 58:14 Closing remarks Copyright 2021 SumZero Inc (www.sumzero.com). No portion of this video - including any excerpted audio - may be used without express written permission from the copyright holders.
SumZero •

Legendary Value Investor Mohnish Pabrai on Turkish Stocks, Big Tech and his $650k Lunch with Warren Buffett

When we last spoke to Mohnish Pabrai in April 2020, his confidence was as unwavering as ever. While gloom seemed to grip the market, Mohnish and other value investors were hunting down deeply discounted stocks in the fire sale that followed the March crash, marking a resurgence of active investing. Amidst the sell-offs in the uncertainty generated by the pandemic, Mohnish Pabrai seemed almost serene. "This too shall pass," he told SumZero.
SumZero •

EXCLUSIVE VIDEO: Divya Narendra Interviews Cameron and Tyler Winklevoss on Bitcoin, Ethereum, NFTs, Crypto, and More

Gemini founders Cameron and Tyler Winklevoss are probably the most well-known cryptocurrency investors in the world and for good reason: according to the New York Times, the two were early acolytes of blockchain-powered currency, having held positions in Bitcoin since 2012 before expanding to other coins and eventually launching the Gemini trading platform in 2015.
SumZero •

Curtains or Comeback? Movie Theaters and Studios Adapt or Die During Pandemic

The news that Disney (DIS: US) plans to release the live-action version of Mulan with an additional $29.99 on-demand price tag to Disney+ subscribers shone a spotlight on one of the biggest questions impacting the film industry as the COVID-19 crisis continues to hamstring the economy: how will new cinematic releases be affected if movie theaters remain closed or if audiences stop going to movies? While filming and production have been delayed or halted altogether on some features, Hollyw
K.S. Anthony •

Plagues, Apocalypses, and Other Banalities

"It hadn't occurred to me until recently that most people are optimists, believing in a tidy model of the universe where things always regress to the mean and follow a predictable ebb and flow that they can model. They never really get that fat-tail, multi-sigma events (so-called "Black Swan" events that, according to standard statistical models should be so mathematically impossible as to be invisible) not only happen with observable frequency, but have effects that are incredibly unpredictable (and in this case quite destructive) with second and third order effects that are similarly unpredictable."
SumZero •

Fight or Flight? Two Deep Value Investments While Air Travel is Grounded

As the COVID19 virus continues to disrupt the market, contributing to the historical plunge that briefly halted trading on Monday, March 9th and again on Thursday, March 12th, some portfolio and fund managers are looking to the skies for deep value investments. No, they’re not experiencing religious epiphanies: they’re proselytizing the virtues of buying into various aspects of air travel...
SumZero •

Irrational Exuberance: An Interview With WallStreetBets Founder Jaime Rogozinski

While SumZero has served the professional BuySide community since 2008, we would be remiss if we did not comment on trends that affect the financial ecosystem. As many have noted in recent weeks, there is an undeniable impact being made by retail investors that affect the market as a whole. Among them is Reddit’s WallStreetBets. Our aim was to avoid sensationalist coverage and examine this phenomenon as objectively as possible to better serve our members. – Editor Irrational Exuberan
SumZero •

Anti-Viral: Two Biotech Stocks Rising With COVID-19

With the COVID-19 coronavirus dominating the headlines and sparking a downturn across broad swaths of the market, many investors are looking to those who are leading the way in the search for either a vaccine, a cure, or both. While many in pharma and biotech are contributing research to this global health crisis, two companies are at the forefront of this battle: Gilead Sciences Inc. (GILD:US) and Moderna Inc. (MRNA:US). Not only have both GILD and MRNA seen significant increases in an otherwis
SumZero •

Peloton and Nautilus: The Long and Short of Fiscal Fitness

The biggest change in exercise machines is the adoption of endogenous technology intended to quantify performance or physiological metrics. Speedometers, pedometers, heart rate monitors, and calorie calculators – once separate tools – can now be found on the least advanced stationary bicycles or treadmills at nearly any gym across the world as well as in wearable devices and phones. At a certain point, the number of useful metrics drops off for the average exerciser.
Outer Places •

A Stalker's Dream: Startup Scraped Billions of Images From Social Media for Facial Recognition AI

An artificial intelligence start-up that has scraped billions of images from social media websites – in likely violation of the sites' terms of service – for facial recognition use by law enforcement agencies is renewing concerns among privacy advocates who fear that the technology could eventually make stalking a complete stranger as easy as taking a picture. The company, Clearview AI, Inc. , was
Load More Articles
Close ✕

Subscribe to get sent a digest of new articles by K.S. Anthony

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

One-click unsubscribe anytime, your email will not be used for anything else.